Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma

Citation
H. Yamamoto et al., Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma, CANCER, 91(7), 2001, pp. 1324-1331
Citations number
27
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER
ISSN journal
0008543X → ACNP
Volume
91
Issue
7
Year of publication
2001
Pages
1324 - 1331
Database
ISI
SICI code
0008-543X(20010401)91:7<1324:AOTEWR>2.0.ZU;2-G
Abstract
BACKGROUND. Overexpression of the matrix serine proteinase (MSP) trypsin ha s been implicated in tumor growth, invasion, and metastasis. The objective of this study was to clarify the clinicopathologic and prognostic significa nce of trypsin expression in esophageal squamous cell carcinomas (SCC). METHODS. Production of trypsin in tissue extracts was analyzed by immunoblo tting and gelatin zymography. The authors analyzed the association between immunohistochemically detected trypsin expression in esophageal SCC and cli nicopathologic characteristics, and they investigated whether trypsin is a predictor of recurrence and/or survival. RESULTS. Overproduction and activation of trypsin was observed in 6 of 10 t umor extracts. The trypsin immunoreactivities at the invasive front were mo re intense than those at the superficial layer. Sections with immunostainin g signals in greater than 30% of carcinoma cells at the invasive front, whi ch were observed in 52 (52%) cases, were judged to be positive for trypsin. Trypsin positivity was significantly correlated with the depth of invasion (P < 0.0001), lymph node metastasis (P = 0.0048), advanced pTNM classifica tion (P = 0.0006), recurrence (P = 0.0003), and recurrence within the first postoperative year (P = 0.0005). Patients with trypsin positive carcinoma had significantly shorter disease free and overall survival times than did those with trypsin negative carcinoma (P < 0.0001 and P 0.0001, respectivel y). Trypsin retained its significant predictive value for disease free and overall survival in multivariate analysis that included conventional clinic opathologic factors (P = 0.0029 and P = 0.0006, respectively). Patients wit h concomitant overexpression of trypsin and matrilysin at the invasive fron t, in which they often were colocalized, had the worst prognosis. CONCLUSIONS, The authors' results suggest that trypsin plays a key role in the progression of esophageal carcinoma. Detection of trypsin expression as well as matrilysin is useful for the prediction of recurrence and poor pro gnosis. (C) 2001 American Cancer Society.